Daniel Reif, Inc., which operates as The Medicine Shoppe in Kansas City, Kansas, has agreed to pay $200,000 to settle allegations that it violated the civil provisions of the Controlled Substances Act (CSA). According to federal authorities, the pharmacy failed to maintain complete and accurate records and inventories of controlled substances from December 31, 2021, through approximately February 23, 2023. Additionally, it did not keep required certification records for retail sales under the Combat Methamphetamine Epidemic Act of 2005.
The CSA was enacted by Congress to establish a tightly regulated system for distributing controlled substances. Regulations require registrants with the Drug Enforcement Administration (DEA) to keep thorough records on all controlled substances they handle. These measures are intended to prevent diversion and abuse.
U.S. Attorney Ryan A. Kriegshauser stated: “The Department of Justice scrutinizes pharmaceutical records for irregularities or suspicious patterns in how controlled substances are prescribed and dispensed. Without reliable data, we are immensely disadvantaged in our ultimate goal, which is to save lives by preventing the misuse of prescription narcotics. This settlement demonstrates the Department of Justice’s commitment to enforcing these rules.”
DEA Special Agent in Charge Michael Davis commented: “Failure to comply with laws and regulations set forth to protect the health of Americans comes with a hefty price tag. Daniel Reif, owner and Pharmacist-in-Charge of Medicine Shoppe Pharmacy, learned that lesson. Registrants are held to high standards and the DEA works to ensure that these individuals are held accountable for their actions.”
The investigation was conducted by the DEA Diversion Control Division’s Kansas City Field Office. Assistant U.S. Attorney Jon Fleenor managed the case as Affirmative Civil Enforcement Coordinator.
Authorities emphasized that while these claims have been resolved through settlement, there has been no determination of liability.
